Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / Denali Therapeutics Inc.

Denali Therapeutics Inc.

Stage unknownSouth San Francisco, CAdenalitherapeutics.comBiotechnology
Facts
Year of incorporation
unknown
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
1
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
2
Financing history
1 rounds
  1. Feb 29, 2024
    Form D equity offering · $500M (form d sold) · 11 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “Denali Therapeutics Inc. filed Form D: $499,732,711 sold of $499,732,711, Biotechnology”
Investors on record
2 edges
People
3 officers, 9 directors
Timeline
1
  1. Mar 1, 2024
    Denali Therapeutics Inc. filed Form D: $499,732,711 sold of $499,732,711, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
18 observations
Every observation on this company